Your browser doesn't support javascript.
loading
Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma.
Kuzman, James A; Stenehjem, David D; Merriman, Joseph; Agarwal, Archana M; Patel, Shiven B; Hahn, Andrew W; Alex, Anitha; Albertson, Dan; Gill, David M; Agarwal, Neeraj.
Afiliação
  • Kuzman JA; University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Stenehjem DD; University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Merriman J; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
  • Agarwal AM; University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Patel SB; Department of Pathology and ARUP Laboratories, University of Utah, Salt Lake City, UT, USA.
  • Hahn AW; University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Alex A; University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Albertson D; University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Gill DM; University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Agarwal N; University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.
BMC Urol ; 17(1): 1, 2017 Jan 05.
Article em En | MEDLINE | ID: mdl-28056941

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos / Carcinoma de Células Renais / Interleucina-2 / Neoplasias Renais / Neutrófilos / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos / Carcinoma de Células Renais / Interleucina-2 / Neoplasias Renais / Neutrófilos / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article